Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Is the dose of dabigatran really more predictable than warfarin?

Literature DB >> 23617900

Is the dose of dabigatran really more predictable than warfarin?

Daniel F B Wright¹, Hesham S Al-Sallami, Stephen B Duffull.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2013 PMID： 23617900 PMCID： PMC3845324 DOI： 10.1111/bcp.12144

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

7 in total

1. Is the ideal anticoagulant a myth?

Authors: Stephen B Duffull
Journal: Expert Rev Clin Pharmacol Date: 2012-05 Impact factor: 5.045

2. Optimizing the dose of dabigatran etexilate.

Authors: John Posner
Journal: Br J Clin Pharmacol Date: 2012-11 Impact factor: 4.335

3. A PK-PD model for predicting the impact of age, CYP2C9, and VKORC1 genotype on individualization of warfarin therapy.

Authors: A-K Hamberg; M-L Dahl; M Barban; M G Scordo; M Wadelius; V Pengo; R Padrini; E N Jonsson
Journal: Clin Pharmacol Ther Date: 2007-02-14 Impact factor: 6.875

4. The population pharmacokinetics of R- and S-warfarin: effect of genetic and clinical factors.

Authors: Steven Lane; Sameh Al-Zubiedi; Ellen Hatch; Ivan Matthews; Andrea L Jorgensen; Panos Deloukas; Ann K Daly; B Kevin Park; Leon Aarons; Kayode Ogungbenro; Farhad Kamali; Dyfrig Hughes; Munir Pirmohamed
Journal: Br J Clin Pharmacol Date: 2012-01 Impact factor: 4.335

5. Population pharmacokinetic analysis of the new oral thrombin inhibitor dabigatran etexilate (BIBR 1048) in patients undergoing primary elective total hip replacement surgery.

Authors: Iñaki F Trocóniz; Christiane Tillmann; Karl-Heinz Liesenfeld; Hans-Günter Schäfer; Joachim Stangier
Journal: J Clin Pharmacol Date: 2007-03 Impact factor: 3.126

6. The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans.

Authors: Stefan Blech; Thomas Ebner; Eva Ludwig-Schwellinger; Joachim Stangier; Willy Roth
Journal: Drug Metab Dispos Date: 2007-11-15 Impact factor: 3.922

7. Dabigatran: rational dose individualisation and monitoring guidance is needed.

Authors: Stephen B Duffull; Daniel F B Wright; Hesham S Al-Sallami; Paul J Zufferey; James M Faed
Journal: N Z Med J Date: 2012-06-29

7 in total

3 in total